Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals

View source ↗

Summary

A completed clinical trial evaluated whether a pre-session supplemental dose of hydromorphone influences drug-seeking behavior in opioid-dependent individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydromorphone (hydromorphone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Heroin Dependence, Opioid-Related Disorders | Status: COMPLETED